Cargando…

Anion Gap Toxicity in Alloxan Induced Type 2 Diabetic Rats Treated with Antidiabetic Noncytotoxic Bioactive Compounds of Ethanolic Extract of Moringa oleifera

Moringa oleifera (MO) is used for a number of therapeutic purposes. This raises the question of safety and possible toxicity. The objective of the study was to ascertain the safety and possible metabolic toxicity in comparison with metformin, a known drug associated with acidosis. Animals confirmed...

Descripción completa

Detalles Bibliográficos
Autores principales: Omabe, Maxwell, Nwudele, Chibueze, Omabe, Kenneth Nwobini, Okorocha, Albert Egwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274870/
https://www.ncbi.nlm.nih.gov/pubmed/25548560
http://dx.doi.org/10.1155/2014/406242
_version_ 1782350052918820864
author Omabe, Maxwell
Nwudele, Chibueze
Omabe, Kenneth Nwobini
Okorocha, Albert Egwu
author_facet Omabe, Maxwell
Nwudele, Chibueze
Omabe, Kenneth Nwobini
Okorocha, Albert Egwu
author_sort Omabe, Maxwell
collection PubMed
description Moringa oleifera (MO) is used for a number of therapeutic purposes. This raises the question of safety and possible toxicity. The objective of the study was to ascertain the safety and possible metabolic toxicity in comparison with metformin, a known drug associated with acidosis. Animals confirmed with diabetes were grouped into 2 groups. The control group only received oral dose of PBS while the test group was treated with ethanolic extract of MO orally twice daily for 5-6 days. Data showed that the extract significantly lowered glucose level to normal values and did not cause any significant cytotoxicity compared to the control group (P = 0.0698); there was no gain in weight between the MO treated and the control groups (P > 0.8115). However, data showed that treatment with an ethanolic extract of MO caused a decrease in bicarbonate (P < 0.0001), and more than twofold increase in anion gap (P < 0.0001); metformin treatment also decreased bicarbonate (P < 0.0001) and resulted in a threefold increase in anion gap (P < 0.0001). Conclusively, these data show that while MO appears to have antidiabetic and noncytotoxic properties, it is associated with statistically significant anion gap acidosis in alloxan induced type 2 diabetic rats.
format Online
Article
Text
id pubmed-4274870
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-42748702014-12-29 Anion Gap Toxicity in Alloxan Induced Type 2 Diabetic Rats Treated with Antidiabetic Noncytotoxic Bioactive Compounds of Ethanolic Extract of Moringa oleifera Omabe, Maxwell Nwudele, Chibueze Omabe, Kenneth Nwobini Okorocha, Albert Egwu J Toxicol Research Article Moringa oleifera (MO) is used for a number of therapeutic purposes. This raises the question of safety and possible toxicity. The objective of the study was to ascertain the safety and possible metabolic toxicity in comparison with metformin, a known drug associated with acidosis. Animals confirmed with diabetes were grouped into 2 groups. The control group only received oral dose of PBS while the test group was treated with ethanolic extract of MO orally twice daily for 5-6 days. Data showed that the extract significantly lowered glucose level to normal values and did not cause any significant cytotoxicity compared to the control group (P = 0.0698); there was no gain in weight between the MO treated and the control groups (P > 0.8115). However, data showed that treatment with an ethanolic extract of MO caused a decrease in bicarbonate (P < 0.0001), and more than twofold increase in anion gap (P < 0.0001); metformin treatment also decreased bicarbonate (P < 0.0001) and resulted in a threefold increase in anion gap (P < 0.0001). Conclusively, these data show that while MO appears to have antidiabetic and noncytotoxic properties, it is associated with statistically significant anion gap acidosis in alloxan induced type 2 diabetic rats. Hindawi Publishing Corporation 2014 2014-12-08 /pmc/articles/PMC4274870/ /pubmed/25548560 http://dx.doi.org/10.1155/2014/406242 Text en Copyright © 2014 Maxwell Omabe et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Omabe, Maxwell
Nwudele, Chibueze
Omabe, Kenneth Nwobini
Okorocha, Albert Egwu
Anion Gap Toxicity in Alloxan Induced Type 2 Diabetic Rats Treated with Antidiabetic Noncytotoxic Bioactive Compounds of Ethanolic Extract of Moringa oleifera
title Anion Gap Toxicity in Alloxan Induced Type 2 Diabetic Rats Treated with Antidiabetic Noncytotoxic Bioactive Compounds of Ethanolic Extract of Moringa oleifera
title_full Anion Gap Toxicity in Alloxan Induced Type 2 Diabetic Rats Treated with Antidiabetic Noncytotoxic Bioactive Compounds of Ethanolic Extract of Moringa oleifera
title_fullStr Anion Gap Toxicity in Alloxan Induced Type 2 Diabetic Rats Treated with Antidiabetic Noncytotoxic Bioactive Compounds of Ethanolic Extract of Moringa oleifera
title_full_unstemmed Anion Gap Toxicity in Alloxan Induced Type 2 Diabetic Rats Treated with Antidiabetic Noncytotoxic Bioactive Compounds of Ethanolic Extract of Moringa oleifera
title_short Anion Gap Toxicity in Alloxan Induced Type 2 Diabetic Rats Treated with Antidiabetic Noncytotoxic Bioactive Compounds of Ethanolic Extract of Moringa oleifera
title_sort anion gap toxicity in alloxan induced type 2 diabetic rats treated with antidiabetic noncytotoxic bioactive compounds of ethanolic extract of moringa oleifera
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274870/
https://www.ncbi.nlm.nih.gov/pubmed/25548560
http://dx.doi.org/10.1155/2014/406242
work_keys_str_mv AT omabemaxwell aniongaptoxicityinalloxaninducedtype2diabeticratstreatedwithantidiabeticnoncytotoxicbioactivecompoundsofethanolicextractofmoringaoleifera
AT nwudelechibueze aniongaptoxicityinalloxaninducedtype2diabeticratstreatedwithantidiabeticnoncytotoxicbioactivecompoundsofethanolicextractofmoringaoleifera
AT omabekennethnwobini aniongaptoxicityinalloxaninducedtype2diabeticratstreatedwithantidiabeticnoncytotoxicbioactivecompoundsofethanolicextractofmoringaoleifera
AT okorochaalbertegwu aniongaptoxicityinalloxaninducedtype2diabeticratstreatedwithantidiabeticnoncytotoxicbioactivecompoundsofethanolicextractofmoringaoleifera